Just Biotherapeutics, Inc.
Records under this name other than patents Just Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Just Biotherapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,098,310 | Expression from Transposon-Based Vectors and Uses Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,028,410 | Hybrid Promoter and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,135,266 | Aflibercept Formulations and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,261,462 | Inducible expression from transposon-based vectors and uses Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,358,983 | Method of purifying glycosylated protein from host cell galectins and other contaminants Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,845,788 | Antibody Therapies for Human Immunodeficiency Virus (HIV) Formerly held In force · High confidence | In force | High confidence | |
| US 11,804,283 | Predicting molecular properties of molecular variants using residue-specific molecular structural features Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,408,840 | High throughput interrogation of physiochemical properties of a protein Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,312,578 | Facilities and processes to produce biotherapeutics Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,441,782 | Anti-HIV Antibody 10-1074 Variants Formerly held In force · High confidence | In force | High confidence |